BACKGROUND AND PURPOSE: The prospect of new therapies in MLD stresses the need to refine the indications for treatment. The aim of this study was, therefore, to perform a detailed analysis of MRI brain lesions at diagnosis and follow-up, to better understand the natural history of MLD. MATERIAL AND METHODS: This retrospective case-control study (2005-2010) looked at 13 patients with MLD (2-5 years of age) with 28 MRIs (mean follow-up, 2 years), compared with 39 age- and sex-matched controls. All MRIs were evaluated qualitatively and semiquantitatively. The Student t test, Wilcoxon signed rank test, and Pearson correlation were used for statistical analysis (P < .05). RESULTS: In addition to diffuse symmetric supratentorial WM T2 hyperintensities with a tigroid pattern (70%) and T2 hyperintensities in the CC (100%) and internal capsules (46%), we found significant GM abnormalities such as thalamic T2 hypointensity (92%), thalamic (23%, P < .05, EJ) and caudate nuclei (23%, P < .05, EJ) atrophy, and cerebellar atrophy without WM involvement (15%). The pattern of splenium involvement progression was misleading, with initially diffuse high signal intensity, which later became curvilinear before finally progressing to atrophy (23%, P < .05; EJ). This should not be mistaken for a disease regression. Spectroscopy confirmed a decrease in the NAA/Cr ratio, an increase in the Cho/Cr ratio and in myo-inositol, and a lactate resonance. CONCLUSIONS: Thalamic changes may be a common finding in MLD, raising the prospect of primary GM lesions. This may prove important when evaluating the efficacy of new treatments.
BACKGROUND AND PURPOSE: The prospect of new therapies in MLD stresses the need to refine the indications for treatment. The aim of this study was, therefore, to perform a detailed analysis of MRI brain lesions at diagnosis and follow-up, to better understand the natural history of MLD. MATERIAL AND METHODS: This retrospective case-control study (2005-2010) looked at 13 patients with MLD (2-5 years of age) with 28 MRIs (mean follow-up, 2 years), compared with 39 age- and sex-matched controls. All MRIs were evaluated qualitatively and semiquantitatively. The Student t test, Wilcoxon signed rank test, and Pearson correlation were used for statistical analysis (P < .05). RESULTS: In addition to diffuse symmetric supratentorial WM T2 hyperintensities with a tigroid pattern (70%) and T2 hyperintensities in the CC (100%) and internal capsules (46%), we found significant GM abnormalities such as thalamic T2 hypointensity (92%), thalamic (23%, P < .05, EJ) and caudate nuclei (23%, P < .05, EJ) atrophy, and cerebellar atrophy without WM involvement (15%). The pattern of splenium involvement progression was misleading, with initially diffuse high signal intensity, which later became curvilinear before finally progressing to atrophy (23%, P < .05; EJ). This should not be mistaken for a disease regression. Spectroscopy confirmed a decrease in the NAA/Cr ratio, an increase in the Cho/Cr ratio and in myo-inositol, and a lactate resonance. CONCLUSIONS: Thalamic changes may be a common finding in MLD, raising the prospect of primary GM lesions. This may prove important when evaluating the efficacy of new treatments.
Authors: Robert A Bermel; Srinivas R Puli; Richard A Rudick; Bianca Weinstock-Guttman; Elizabeth Fisher; Frederick E Munschauer; Rohit Bakshi Journal: Arch Neurol Date: 2005-09
Authors: S Mesaros; M A Rocca; M Absinta; A Ghezzi; N Milani; L Moiola; P Veggiotti; G Comi; M Filippi Journal: Neurology Date: 2008-02-13 Impact factor: 9.910
Authors: Y Ge; J H Jensen; H Lu; J A Helpern; L Miles; M Inglese; J S Babb; J Herbert; R I Grossman Journal: AJNR Am J Neuroradiol Date: 2007-09-24 Impact factor: 3.825
Authors: Conor Fearon; Sapna Rawal; Diana Olszewska; Paula Alcaide-Leon; Drew S Kern; Soumya Sharma; Shyam K Jaiswal; Jagarlapudi M K Murthy; Ainhi D Ha; Raymond S Schwartz; Victor S C Fung; Chauncey Spears; Tracy Tholanikunnel; Leonardo Almeida; Taku Hatano; Yutaka Oji; Nobutaka Hattori; Shantanu Shubham; Hrishikesh Kumar; Roongroj Bhidayasiri; Christopher Laohathai; Anthony E Lang Journal: Mov Disord Clin Pract Date: 2022-02-03
Authors: Parand Zarekiani; Marjolein Breur; Nicole I Wolf; Helga E de Vries; Marjo S van der Knaap; Marianna Bugiani Journal: Acta Neuropathol Commun Date: 2021-06-03 Impact factor: 7.801
Authors: Jan-Mendelt Tillema; Marloes Gm Derks; Petra J W Pouwels; Pim de Graaf; Diane F van Rappard; Frederik Barkhof; Marjan E Steenweg; Marjo S van der Knaap; Nicole I Wolf Journal: Ann Clin Transl Neurol Date: 2015-08-24 Impact factor: 4.511
Authors: Diane F van Rappard; Marsh Königs; Marjan E Steenweg; Jaap Jan Boelens; Jaap Oosterlaan; Marjo S van der Knaap; Nicole I Wolf; Petra J W Pouwels Journal: J Neurol Date: 2018-01-30 Impact factor: 4.849